Helicobacter pylori infection in functional dyspepsia

Nature Reviews Gastroenterology and Hepatology

Volumn 10, Issue 3, 2013, Pages 168-174

  Suzuki, Hidekazu ^a   Moayyedi, Paul ^b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN; GHRELIN; MICRORNA; MICRORNA 1; MICRORNA 133; MICRORNA 133A; MICRORNA 133B; SOMATOSTATIN; ULIMORELIN; UNCLASSIFIED DRUG;

BACTERIAL COLONIZATION; BACTERIUM DETECTION; CHINA; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ASSOCIATION; DISEASE CONTROL; DRUG EFFECT; DYSPEPSIA; ENDOCRINOLOGY; EPIGASTRIC PAIN; ERADICATION THERAPY; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; JAPAN; KOREA; MAST CELL; MICROCIRCULATION; NONHUMAN; PATHOGENESIS; POSTPRANDIAL DISTRESS SYNDROME; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STOMACH ACID SECRETION;

ANTI-BACTERIAL AGENTS; DYSPEPSIA; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL MUCOSA; PREVALENCE; TREATMENT OUTCOME;

EID: 84875230726     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2013.9     Document Type: Review

References (99)

1. Talley, N. J., Phillips, S. F., Melton, J. 3rd, Wiltgen, C. & Zinsmeister, A. R. A patient questionnaire to identify bowel disease. Ann. Intern. Med. 111, 671-674 (1989
2. Ford, A. C., Forman, D., Bailey, A. G., Axon, A. T. & Moayyedi, P. Effect of dyspepsia on survival: A longitudinal 10-year follow-up study. Am. J. Gastroenterol. 107, 912-921 (2012
3. Ford, A. C., Forman, D., Bailey, A. G., Axon, A. T. & Moayyedi, P. Initial poor quality of life and new onset of dyspepsia: Results from a longitudinal 10-year follow-up study. Gut 56, 321-327 (2007
4. Ford, A. C., Marwaha, A., Lim, A. & Moayyedi, P. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsiä Systematic review and meta-Analysis. Clin. Gastroenterol. Hepatol. 8, 830-837 e831-e832 (2010
5. Moayyedi, P. Dyspepsia. Curr. Opin. Gastroenterol. 28, 602-607 (2012
6. Porter, C. K., Gormley, R., Tribble, D. R., Cash, B. D. & Riddle, M. S. The incidence and gastrointestinal infectious risk of functional gastrointestinal disorders in a healthy US adult population. Am. J. Gastroenterol. 106, 130-138 (2011
7. Liebregts, T. et al. Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia. Am. J. Gastroenterol. 106, 1089-1098 (2011
8. Ford, A. C. et al. Prevalence of uninvestigated dyspepsia 8 years after a large waterborne outbreak of bacterial dysentery: A cohort study. Gastroenterology 138, 1727-1736 (2010
9. Bazzoli, F. et al. The Loiano-Monghidoro population-based study of Helicobacter pylori infection: Prevalence by 13C-urea breath test and associated factors. Aliment. Pharmacol. Ther. 15, 1001-1007 (2001
10. Suzuki, M. et al. H. pylori-eradication therapy increases RUNX3 expression in the glandular epithelial cells in enlarged-fold gastritis. J. Clin. Biochem. Nutr. 46, 259-264 (2010
11. Suzuki, H., Nishizawa, T. & Hibi, T. Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification. J. Gastroenterol. 41, 513-523 (2006
12. Suzuki, H., Hibi, T. & Marshall, B. J. Helicobacter pylori: Present status and future prospects in Japan. J. Gastroenterol. 42, 1-15 (2007
13. Suzuki, H., Nishizawa, T., Tsugawa, H., Mogami, S. & Hibi, T. Roles of oxidative stress in stomach disorders. J. Clin. Biochem. Nutr. 50, 35-39 (2012
14. Suzuki, H., Suzuki, M., Imaeda, H. & Hibi, T. Helicobacter pylori and microcirculation. Microcirculation 16, 547-558 (2009
15. Suzuki, S. et al. Delayed gastric emptying and disruption of the interstitial cells of Cajal network after gastric ischaemia and reperfusion. Neurogastroenterol. Motil. 22, 585-593 (2010
16. Mogami, S. et al. Reduced ghrelin production induced anorexia after rat gastric ischemia and reperfusion. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G359-G364 (2012
17. Savarino, E., Zentilin, P., Dulbecco, P., Malesci, A. & Savarino, V. The role of acid in functional dyspepsia. Am. J. Gastroenterol. 106, 1168 (2011
18. El-Omar, E., Penman, I., Dorrian, C. A., Ardill, J. E. & McColl, K. E. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 34, 1060-1065 (1993
19. Amieva, M. R. & El-Omar, E. M. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 134, 306-323 (2008
20. Hurlimann, S. et al. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease. Am. J. Gastroenterol. 93, 1277-1285 (1998
21. McColl, K. E., El-Omar, E. & Gillen, D. Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy. Br. Med. Bull. 54, 121-138 (1998
22. Koike, T. et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 49, 330-334 (2001
23. Moss, S. F., Legon, S., Bishop, A. E., Polak, J. M. & Calam, J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 340, 930-932 (1992
24. Odum, L., Petersen, H. D., Andersen, I. B., Hansen, B. F. & Rehfeld, J. F. Gastrin and somatostatin in Helicobacter pylori infected antral mucosa. Gut 35, 615-618 (1994
25. Kamada, T. et al. The association between antral G and D cells and mucosal inflammation, atrophy, and Helicobacter pylori infection in subjects with normal mucosa, chronic gastritis, and duodenal ulcer. Am. J. Gastroenterol. 93, 748-752 (1998
26. Calam, J., Gibbons, A., Healey, Z. V., Bliss, P. & Arebi, N. How does Helicobacter pylori cause mucosal damage? Its effect on acid and gastrin physiology. Gastroenterology 113, S43-S49 (1997
27. Mulholland, G. et al. Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17. Gut 34, 757-761 (1993
28. Liu, Y., Vosmaer, G. D., Tytgat, G. N., Xiao, S. D. & Ten Kate, F. J. Gastrin (G) cells and somatostatin (D) cells in patients with dyspeptic symptoms: Helicobacter pylori associated and non-Associated gastritis. J. Clin. Pathol. 58, 927-931 (2005
29. Konturek, J. W., Bielanski, W., Konturek, S. J. & Domschke, W. Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients. J. Physiol. Pharmacol. 47, 161-175 (1996
30. Suzuki, H. et al. Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut 53, 187-194 (2004
31. Osawa, H. et al. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J. Clin. Endocrinol. Metab. 90, 10-16 (2005
32. Suzuki, H. et al. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio-A possible novel and non-invasive marker for gastric atrophy. Hepatogastroenterology 51, 1249-1254 (2004
33. Isomoto, H. et al. Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans. Am. J. Gastroenterol. 100, 1711-1720 (2005
34. Dong, C. X. & Brubaker, P. L. Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis. Nat. Rev. Gastroenterol. Hepatol. 9, 705-715 (2012
35. Mori, M. et al. Intravenous ghrelin administration enhances gastric acid secretion -evaluation using wireless pH capsule. Aliment. Pharmacol. Ther. 24, 96-103 (2006
36. Arai, M. et al. Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin. Hepatogastroenterology 59, 62-66 (2012
37. Iijima, K. et al. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut 46, 20-26 (2000
38. Osawa, H. et al. Helicobacter pylori eradication induces marked increase in H+/K+-Adenosine triphosphatase expression without altering parietal cell number in human gastric mucosa. Gut 55, 152-157 (2006
39. Osawa, H. et al. Changes in plasma ghrelin levels, gastric ghrelin production, and body weight after Helicobacter pylori cure. J. Gastroenterol. 41, 954-961 (2006
40. Masaoka, T. et al. Long-Term strict monitoring of plasma ghrelin and other serological markers of gastric diseases after Helicobacter pylori eradication. Hepatogastroenterology 52, 1-4 (2005
41. Tatsuguchi, A. et al. Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa. Am. J. Gastroenterol. 99, 2121-2127 (2004
42. Jang, E. J. et al. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease. J. Gastroenterol. Hepatol. 23 (Suppl. 2), S278-S285 (2008
43. Choe, Y. H. et al. Ghrelin levels in gastric mucosa before and after eradication of Helicobacter pylori. Gut Liver 1, 132-137 (2007
44. Nogueiras, R., Williams, L. M. & Dieguez, C. Ghrelin: New molecular pathways modulating appetite and adiposity. Obes. Facts 3, 285-292 (2010
45. Miyaji, H. et al. The effect of Helicobacter pylori eradication therapy on gastric antral myoelectrical activity and gastric emptying in patients with non-ulcer dyspepsia. Aliment. Pharmacol. Ther. 13, 1473-1480 (1999
46. Matsumoto, Y. et al. Relation between histologic gastritis and gastric motility in Japanese patients with functional dyspepsia: Evaluation by transabdominal ultrasonography. J. Gastroenterol. 43, 332-337 (2008
47. Kachi, M. et al. Effects of Helicobacter pylori eradication therapy on gastric emptying measured using the 13C-octanoic acid breath test and the acetaminophen method. J. Gastroenterol. Hepatol. 21, 824-830 (2006
48. Saito, Y. et al. Dysfunctional gastric emptying with down-regulation of muscle-specific microRNAs in Helicobacter pylori-infected mice. Gastroenterology 140, 189-198 (2011
49. Tack, J. et al. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment. Pharmacol. Ther. 22, 847-853 (2005
50. Murray, C. D. et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: A double blind, placebo controlled, crossover study. Gut 54, 1693-1698 (2005
51. US National Library of Medicine. ClinicalTrials.gov [online], http://www.clinicaltrials.gov/ct2/show/NCT01405599?term=TZP-101&rank=4 (2012
52. Hall, W., Buckley, M., Crotty, P. & O'Morain, C. A. Gastric mucosal mast cells are increased in Helicobacter pylori-negative functional dyspepsia. Clin. Gastroenterol. Hepatol. 1, 363-369 (2003
53. Miyamoto, M. et al. Nodular gastritis in adults is caused by Helicobacter pylori infection. Dig. Dis. Sci. 48, 968-975 (2003
54. Dwivedi, M., Misra, S. P. & Misra, V. Nodular gastritis in adults: Clinical features, endoscopic appearance, histopathological features, and response to therapy. J. Gastroenterol. Hepatol. 23, 943-947 (2008
55. Murayama, Y. et al. Morphological and functional restoration of parietal cells in Helicobacter pylori associated enlarged fold gastritis after eradication. Gut 45, 653-661 (1999
56. Matsunari, O. et al. Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. J. Clin. Microbiol. 50, 876-883 (2012
57. Suzuki, H., Nishizawa, T. & Hibi, T. Can Helicobacter pylori-Associated dyspepsia be categorized as functional dyspepsiä J. Gastroenterol. Hepatol. 26 (Suppl. 3), 42-45 (2011
58. Suzuki, H., Matsuzaki, J. & Hibi, T. What is the difference between Helicobacter pylori-Associated dyspepsia and functional dyspepsiä J. Neurogastroenterol. Motil. 17, 124-130 (2011
59. Sugano, K. Should we still subcategorize Helicobacter pylori-Associated dyspepsia as functional disease? J. Neurogastroenterol. Motil. 17, 366-371 (2011
60. Yagi, K., Aruga, Y., Nakamura, A. & Sekine, A. Regular arrangement of collecting venules (RAC): A characteristic endoscopic feature of Helicobacter pylori-negative normal stomach and its relationship with esophago-gastric adenocarcinoma. J. Gastroenterol. 40, 443-452 (2005
61. Anagnostopoulos, G. K. et al. High-resolution magnification endoscopy can reliably identify normal gastric mucosa, Helicobacter pylori-Associated gastritis, and gastric atrophy. Endoscopy 39, 202-207 (2007
62. Suzuki, H. et al. Current consensus on the diagnosis and treatment of H. pylori-Associated gastroduodenal disease. Keio J. Med. 52, 163-173 (2003
63. McColl, K. et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N. Engl. J. Med. 339, 1869-1874 (1998
64. Blum, A. L. et al. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin effect one year after treatment (OCAY) Study Group. N. Engl. J. Med. 339, 1875-1881 (1998
65. Laine, L., Schoenfeld, P. & Fennerty, M. B. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-Analysis of randomized, controlled trials. Ann. Intern. Med. 134, 361-369 (2001
66. Moayyedi, P. et al. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ 321, 659-664 (2000
67. Moayyedi, P., Deeks, J., Talley, N. J., Delaney, B. & Forman, D. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: Resolving the discrepancy between systematic reviews. Am. J. Gastroenterol. 98, 2621-2626 (2003
68. Mazzoleni, L. E. et al. Helicobacter pylori eradication in functional dyspepsia: HEROES trial. Arch. Intern. Med. 171, 1929-1936 (2011
69. Moayyedi, P. Helicobacter pylori eradication for functional dyspepsia: What are we treating?: Comment on "Helicobacter pylori eradication in functional dyspepsia". Arch. Intern. Med. 171, 1936-1937 (2011
70. Moayyedi, P. et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD002096. doi:10.1002/14651858.CD002096.pub5 (2006
71. Jin, X. & Li, Y. M. Systematic review and meta-Analysis from Chinese literature: The association between Helicobacter pylori eradication and improvement of functional dyspepsia. Helicobacter 12, 541-546 (2007
72. Moayyedi, P., Delaney, B. C., Vakil, N., Forman, D. & Talley, N. J. The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis. Gastroenterology 127, 1329-1337 (2004
73. Moayyedi, P. et al. Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment. Pharmacol. Ther. 17, 1215-1227 (2003
74. Abraham, N. S., Moayyedi, P., Daniels, B. & Veldhuyzen Van Zanten, S. J. Systematic review: The methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia. Aliment. Pharmacol. Ther. 19, 631-641 (2004
75. Kindt, S. et al. Longitudinal and cross-sectional factors associated with long-Term clinical course in functional dyspepsia: A 5-year follow-up study. Am. J. Gastroenterol. 106, 340-348 (2011
76. Moayyedi, P. & Leontiadis, G. I. The risks of PPI therapy. Nat. Rev. Gastroenterol. Hepatol. 9, 132-139 (2012
77. Basu, P. P. et al. A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori. Am. J. Gastroenterol. 106, 1970-1975 (2011
78. Watson, J. B. & Moss, S. F. Will H. pylori stagger under the weight of this LOAD? A novel but expensive eradication regimen. Am. J. Gastroenterol. 106, 1976-1977 (2011
79. Geeraerts, B. & Tack, J. Functional dyspepsia: Past, present, and future. J. Gastroenterol. 43, 251-255 (2008
80. Tack, J., Masaoka, T. & Janssen, P. Functional dyspepsia. Curr. Opin. Gastroenterol. 27, 549-557 (2011
81. Talley, N. J., Janssens, J., Lauritsen, K., Racz, I. & Bolling-Sternevald, E. Eradication of Helicobacter pylori in functional dyspepsia: Randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. BMJ 318, 833-837 (1999
82. Hsu, P. I. et al. Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia. Aliment. Pharmacol. Ther. 15, 195-201 (2001
83. Gwee, K. A. et al. The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. Eur. J. Gastroenterol. Hepatol. 21, 417-424 (2009
84. Bruley Des Varannes, S. et al. There are some benefits for eradicating Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment. Pharmacol. Ther. 15, 1177-1185 (2001
85. Lan, L. et al. Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia. World J. Gastroenterol. 17, 3242-3247 (2011
86. Lee, K. J., Vos, R., Janssens, J. & Tack, J. Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G278-G284 (2004
87. Ang, D. et al. Influence of ghrelin on the gastric accommodation reflex and on meal-induced satiety in man. Neurogastroenterol. Motil. 21, 528-533 (2009
88. Lacy, B. E. et al. Review article: Current treatment options and management of functional dyspepsia. Aliment. Pharmacol. Ther. 36, 3-15 (2012
89. Bytzer, P. et al. Diagnosis and treatment of Helicobacter pylori infection. Dan. Med. Bull. 58, C4271 (2011
90. Jee, S. R. et al. Guidelines for the treatment of functional dyspepsia [Korean]. Korean J. Gastroenterol. 57, 67-81 (2011
91. Fischbach, W. Short version of the S3 (level 3) guideline "Helicobacter pylori and gastroduodenal ulcer disease" from the German Society for Digestive and Metabolic Diseases [German]. Dtsch. Med. Wochenschr. 134, 1830-1834 (2009
92. Chey, W. D. & Wong, B. C. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am. J. Gastroenterol. 102, 1808-1825 (2007
93. Fock, K. M. et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J. Gastroenterol. Hepatol. 24, 1587-1600 (2009
94. Miwa, H. et al. Asian consensus report on functional dyspepsia. J. Gastroenterol. Hepatol. 27, 626-641 (2012
95. Asaka, M. et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 15, 1-20 (2010
96. Malfertheiner, P. et al. Management of Helicobacter pylori infection -The Maastricht IV/ Florence Consensus Report. Gut 61, 646-664 (2012
97. Ford, A. C., Delaney, B. C., Forman, D. & Moayyedi, P. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: Systematic review and economic analysis. Am. J. Gastroenterol. 99, 1833-1855 (2004
98. Sanchez-Delgado, J. et al. Has H. pylori prevalence in bleeding peptic ulcer been underestimated? A meta-regression. Am. J. Gastroenterol. 106, 398-405 (2011
99. Gonzalez, C. A. et al. Helicobacter pylori cagA and vacA genotypes as predictors of progression of gastric preneoplastic lesions: A long-Term follow-up in a high-risk area in Spain. Am. J. Gastroenterol. 106, 867-874 (2011